HK1072894A1 - The use of epidermal growth factor (egf) for increasing weight gain in an animal - Google Patents

The use of epidermal growth factor (egf) for increasing weight gain in an animal

Info

Publication number
HK1072894A1
HK1072894A1 HK05104375A HK05104375A HK1072894A1 HK 1072894 A1 HK1072894 A1 HK 1072894A1 HK 05104375 A HK05104375 A HK 05104375A HK 05104375 A HK05104375 A HK 05104375A HK 1072894 A1 HK1072894 A1 HK 1072894A1
Authority
HK
Hong Kong
Prior art keywords
egf
animal
growth factor
weight gain
epidermal growth
Prior art date
Application number
HK05104375A
Other languages
English (en)
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Publication of HK1072894A1 publication Critical patent/HK1072894A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK05104375A 1995-05-10 2005-05-24 The use of epidermal growth factor (egf) for increasing weight gain in an animal HK1072894A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
HK1072894A1 true HK1072894A1 (en) 2005-09-16

Family

ID=23742496

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104375A HK1072894A1 (en) 1995-05-10 2005-05-24 The use of epidermal growth factor (egf) for increasing weight gain in an animal

Country Status (13)

Country Link
US (2) US5753622A (xx)
EP (3) EP1479394B1 (xx)
JP (1) JP3549541B2 (xx)
AT (3) ATE357927T1 (xx)
AU (1) AU704675B2 (xx)
CA (2) CA2220434C (xx)
DE (3) DE69637002T2 (xx)
DK (3) DK1479394T3 (xx)
ES (2) ES2226681T3 (xx)
HK (1) HK1072894A1 (xx)
NZ (2) NZ501482A (xx)
PT (1) PT1479394E (xx)
WO (1) WO1996035445A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
CN1527879A (zh) * 2001-05-18 2004-09-08 加拿大农业及农业食品部 牛表皮生长因子的核酸序列和蛋白质序列
WO2003035102A1 (en) * 2001-10-26 2003-05-01 University Technologies International, Inc. Use of egf to inhibit pathogenic infections of the urogenital tract
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
AU2003250250B2 (en) 2002-06-19 2008-02-14 Intrexon Actobiotics Nv Methods and means to promote gut absorption
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
US20110275566A1 (en) * 2008-10-10 2011-11-10 Nationwide Children's Hospital Inc. Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
ATE80307T1 (de) * 1986-12-11 1992-09-15 British Tech Group Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
DK1479394T3 (da) 2007-06-11
DE69637002D1 (de) 2007-05-10
ATE357927T1 (de) 2007-04-15
US6656907B1 (en) 2003-12-02
JPH11505528A (ja) 1999-05-21
DK0824357T3 (da) 2001-10-08
DE69614377D1 (de) 2001-09-13
EP1479394B1 (en) 2007-03-28
ATE203912T1 (de) 2001-08-15
DE69614377T2 (de) 2002-05-23
EP1092437B1 (en) 2004-10-06
CA2492724C (en) 2010-08-03
EP0824357B1 (en) 2001-08-08
ES2226681T3 (es) 2005-04-01
AU5641196A (en) 1996-11-29
DE69633583D1 (de) 2004-11-11
ATE278415T1 (de) 2004-10-15
EP0824357A1 (en) 1998-02-25
AU704675B2 (en) 1999-04-29
EP1479394A1 (en) 2004-11-24
JP3549541B2 (ja) 2004-08-04
DK1092437T3 (da) 2005-01-31
DE69637002T2 (de) 2007-08-16
CA2220434C (en) 2005-02-22
WO1996035445A1 (en) 1996-11-14
DE69633583T2 (de) 2006-02-23
CA2220434A1 (en) 1996-11-14
US5753622A (en) 1998-05-19
NZ307134A (en) 2000-02-28
EP1092437A1 (en) 2001-04-18
ES2285320T3 (es) 2007-11-16
NZ501482A (en) 2004-12-24
PT1479394E (pt) 2007-04-30
CA2492724A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
HK1072894A1 (en) The use of epidermal growth factor (egf) for increasing weight gain in an animal
GR3006124T3 (xx)
ATE301937T1 (de) Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien
DE3164696D1 (en) 1-hydroxyethyl-azole derivatives, process for their preparation and their use in the regulation of plant growth and as fungicides
AU1277688A (en) Sustained release compositions for parenteral administration and their use
HUT64086A (en) Process for producing gh-crystals
EP0274363A3 (en) Product and process for an efficient skin-hydrating treatment, especially for use in the field of cosmetics
AU1577388A (en) Product for proteolysis of all proteins
AU7184987A (en) Aroma composition, the use thereof and the process for the preparation thereof
AU589970B2 (en) Animal litter and process for the production thereof
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
EP0192222A3 (en) Agent for preventing, decreasing or retarding the protein decomposition in the human or animal digestive tract, and process for its production
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
SU1522498A1 (ru) Дезинфицирующее средство
EP0259713A3 (en) Synthetic feed milk substitutes, especially for dogs
CN1135297A (zh) 硫酸蛋氨酸金属配合物在牛蛙养殖中的应用
MD512C2 (ro) Inhibitor dezvoltării mugurilor la altoaiele viţei de vie
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
HUT62770A (en) Method for producing preparation improving the fodder utilization and health condition and increasing animal yield and using the same in mixture-fodders
HUT42299A (en) Method for producing farinaceous foodstuffs
MY111534A (en) Hydroxycitric acid concentrate and food products prepared therefrom.
CA2031825A1 (en) Bath additive and its use
CA2127445A1 (en) Nutrient composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130509